Figure 2.
Disease-modifying therapies in ATTRv. Targets of disease-modifying therapies are (1) liver, (2) hepatocytes, (3) circulating TTR, and (4) amyloid deposits in organs (heart, kidneys) and peripheral nervous system.
Disease-modifying therapies in ATTRv. Targets of disease-modifying therapies are (1) liver, (2) hepatocytes, (3) circulating TTR, and (4) amyloid deposits in organs (heart, kidneys) and peripheral nervous system.
